A review on herbal drugs used in parkinson’s disease
Abstract
Parkinson's disease (PD) is the world's most widespread chronic neuron degenerative motion condition affecting more than 10 million people. The characteristic hallmark of PD involves a progressive loss of doperminergic neuron in the brain's Subetantia Nigra. Considerable Beware of this paid recently to the Bio-friendly Usage plant-based products for neuron prevention, cure and treatment Disease and is degenerative. The herbal drugs therefore are safer than other drugs. Herbal medicine has its roots in ancient civilizations. It includes the usage of medicinal plants to cure disease and enhance general well being. Keywords: Parkinson, Herbal Drug Treatment, Ayurveda.
Keywords:
Parkinson, Herbal Drug, Treatment, Ayurveda, medicinal plants
Downloads
Download data is not yet available.
References
1. Zhang H, Tong R, Bai L, Shi J, Ouyang L. Emerging targets and new small molecule therapies in Parkinson’s disease treatment. Bioorganic & medicinal chemistry. 2016 Apr 1; 24 (7):1419-30.
2. Fujikawa T, Miguchi S, Kanada N, Nakai N, Ogata M, Suzuki I, Nakashima K. Acanthopanax senticosus Harms as a prophylactic for MPTP-induced Parkinson's disease in rats. Journal of ethnopharmacology. 2005 Feb 28; 97(2):375-81.
3. Fujikawa T, Kanada N, Shimada A, Ogata M, Suzuki I, Hayashi I, Nakashima K. Effect of Sesamin in Acanthopanax senticosus H ARMS on Behavioral Dysfunction in Rotenone-Induced Parkinsonian Rats. Biological and Pharmaceutical Bulletin. 2005; 28(1):169-72.
4. Huang L, Zhao H, Huang B, Zheng C, Peng W, Qin L. Acanthopanax senticosus: review of botany, chemistry and pharmacology. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2011 Feb 10; 66 (2):83-97.
5. Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson’s disease: new hopes in treatment with herbal antioxidants. Current pharmaceutical design. 2016 Jan 1; 22(2):238-46.
6. Kartika B, Muralidharan P, Rahman H. Herbal treatment of Parkinsons: A review. International Journal of Pharmaceutical Sciences Review and Research. 2010; 5(3):185-91.
7. Manjunath MJ. Standardized extract of Withaniasomnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster. Journal of food science and technology. 2015 Apr 1; 52(4):1971-81.
8. Ittiyavirah SP, Hameed J. Herbs treating Parkinson's disease. Biomedicine & Aging Pathology. 2014 Oct 1; 4(4):369-76.
9. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withaniasomnifera, the Indian ginseng. Cellular and molecular life sciences. 2015 Dec 1; 72(23):4445-60.
10. Flint Beal M. Coenzyme Q 10 as a possible treatment for neurodegenerative diseases. Free Radical Research. 2002 Jan 1; 36(4):455-60.
11. Shinomol GK, Bharath MS. Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in the striatum of prepubertal mouse brain. Canadian journal of physiology and pharmacology. 2012 May; 90(5):595-606.
12. Saviranta NM, Julkunen-Tiitto R, Oksanen E, Karjalainen RO. Leaf phenolic compounds in red clover (Trifoliumpratense L.) induced by exposure to moderately elevated ozone. Environmental Pollution. 2010 Feb 1; 158(2):440-6.
13. Datla KP, Zbarsky V, Rai D, Parkar S, Osakabe N, Aruoma OI, Dexter DT. Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease. Journal of the American College of Nutrition. 2007 Aug 1; 26(4):341-9
14. Liu Y, Chen HL, Yang G. Extract of Tripterygium wilfordii Hook F protect dopaminergic neurons against lipopolysaccharideinduced inflammatory damage. The American journal of Chinese medicine. 2010; 38(04):801-14..
15. Ahmad M, Yousuf S, Khan MB, Hoda MN, Ahmad AS, Ansari MA, Ishrat T, Agrawal AK, Islam F. Attenuation by Nardostachysjatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacology Biochemistry and Behavior. 2006 Jan 1; 83(1):150-60.
16. More SV, Kumar H, Kang SM, Song SY, Lee K, Choi DK. Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson’s disease. Evidence-based complementary and alternative medicine. 2013 Jan 1; 2013.
17. Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees AJ. Mucunapruriens in Parkinson’s disease: a double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery & Psychiatry. 2004 Dec 1; 75(12):1672-7.
18. Abdel-Salam OM. Drugs used to treat Parkinson's disease, present status and future directions. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2008 Oct 1; 7(4):321-42.
19. Ittiyavirah SP, Hameed J. Herbs treating Parkinson's disease. Biomedicine & Aging Pathology. 2014 Oct 1; 4(4):369-76.
20. Hosamani R, Ramesh SR. Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicty in Drosophila melanogaster supplemented with creatine. Neurochemical research. 2010 Sep 1; 35(9):1402-12.
21. Choi HS, Zhao TT, Shin KS, Kim SH, Hwang BY, Lee CK, Lee MK. Anxiolytic effects of herbal ethanol extract from Gynostemmapentaphyllum in mice after exposure to chronic stress. Molecules. 2013 Apr; 18(4):4342-56.
2. Fujikawa T, Miguchi S, Kanada N, Nakai N, Ogata M, Suzuki I, Nakashima K. Acanthopanax senticosus Harms as a prophylactic for MPTP-induced Parkinson's disease in rats. Journal of ethnopharmacology. 2005 Feb 28; 97(2):375-81.
3. Fujikawa T, Kanada N, Shimada A, Ogata M, Suzuki I, Hayashi I, Nakashima K. Effect of Sesamin in Acanthopanax senticosus H ARMS on Behavioral Dysfunction in Rotenone-Induced Parkinsonian Rats. Biological and Pharmaceutical Bulletin. 2005; 28(1):169-72.
4. Huang L, Zhao H, Huang B, Zheng C, Peng W, Qin L. Acanthopanax senticosus: review of botany, chemistry and pharmacology. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2011 Feb 10; 66 (2):83-97.
5. Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson’s disease: new hopes in treatment with herbal antioxidants. Current pharmaceutical design. 2016 Jan 1; 22(2):238-46.
6. Kartika B, Muralidharan P, Rahman H. Herbal treatment of Parkinsons: A review. International Journal of Pharmaceutical Sciences Review and Research. 2010; 5(3):185-91.
7. Manjunath MJ. Standardized extract of Withaniasomnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster. Journal of food science and technology. 2015 Apr 1; 52(4):1971-81.
8. Ittiyavirah SP, Hameed J. Herbs treating Parkinson's disease. Biomedicine & Aging Pathology. 2014 Oct 1; 4(4):369-76.
9. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withaniasomnifera, the Indian ginseng. Cellular and molecular life sciences. 2015 Dec 1; 72(23):4445-60.
10. Flint Beal M. Coenzyme Q 10 as a possible treatment for neurodegenerative diseases. Free Radical Research. 2002 Jan 1; 36(4):455-60.
11. Shinomol GK, Bharath MS. Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in the striatum of prepubertal mouse brain. Canadian journal of physiology and pharmacology. 2012 May; 90(5):595-606.
12. Saviranta NM, Julkunen-Tiitto R, Oksanen E, Karjalainen RO. Leaf phenolic compounds in red clover (Trifoliumpratense L.) induced by exposure to moderately elevated ozone. Environmental Pollution. 2010 Feb 1; 158(2):440-6.
13. Datla KP, Zbarsky V, Rai D, Parkar S, Osakabe N, Aruoma OI, Dexter DT. Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease. Journal of the American College of Nutrition. 2007 Aug 1; 26(4):341-9
14. Liu Y, Chen HL, Yang G. Extract of Tripterygium wilfordii Hook F protect dopaminergic neurons against lipopolysaccharideinduced inflammatory damage. The American journal of Chinese medicine. 2010; 38(04):801-14..
15. Ahmad M, Yousuf S, Khan MB, Hoda MN, Ahmad AS, Ansari MA, Ishrat T, Agrawal AK, Islam F. Attenuation by Nardostachysjatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacology Biochemistry and Behavior. 2006 Jan 1; 83(1):150-60.
16. More SV, Kumar H, Kang SM, Song SY, Lee K, Choi DK. Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson’s disease. Evidence-based complementary and alternative medicine. 2013 Jan 1; 2013.
17. Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees AJ. Mucunapruriens in Parkinson’s disease: a double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery & Psychiatry. 2004 Dec 1; 75(12):1672-7.
18. Abdel-Salam OM. Drugs used to treat Parkinson's disease, present status and future directions. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2008 Oct 1; 7(4):321-42.
19. Ittiyavirah SP, Hameed J. Herbs treating Parkinson's disease. Biomedicine & Aging Pathology. 2014 Oct 1; 4(4):369-76.
20. Hosamani R, Ramesh SR. Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicty in Drosophila melanogaster supplemented with creatine. Neurochemical research. 2010 Sep 1; 35(9):1402-12.
21. Choi HS, Zhao TT, Shin KS, Kim SH, Hwang BY, Lee CK, Lee MK. Anxiolytic effects of herbal ethanol extract from Gynostemmapentaphyllum in mice after exposure to chronic stress. Molecules. 2013 Apr; 18(4):4342-56.
Published
22/09/2023
Statistics
288 Views | 241 Downloads
Citatons
How to Cite
[1]
S. Badri, “A review on herbal drugs used in parkinson’s disease”, Int J Indig Herb Drug, vol. 8, no. 5, pp. 20-26, Sep. 2023.
Issue
Section
Review Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.